CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Universidade de São Paulo (USP). Faculdade de Medicina de Ribeirão Preto (FMRP) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Degree in Medicine (MD) from the Federal University of Juiz de Fora (1996), Dermatologist from the HU-UFJF (1999) and DOCTORATE (PhD) in Clinical Medicine from the Faculty of Medicine of Ribeirão Preto-USP (2003) and POST-DOCTORATE ( Post-PhD) by the ACADEMIC MEDICAL CENTER OF UNIVERSITY OF AMSTERDAM at the Laboratory of Experimental Dermato-Immuno-Pathology. Since 2015, Associate Professor of Dermatology, Department of Medical Clinic, Ribeirão Preto Medical School - USP. Coordinator of the HEALTH HANSENIASIS LABORATORY - FMRP-USP since 2004. President of the Brazilian Society of Leprosy 2012-2014 and 2015-2017. Coordinator National Reference Center for Sanitary Dermatology - Leprosy HCFMRP-USP. Current Full Member of the Graduate Committee on Medical Clinic of FMRP-USP and of the Department Council. Has experience in Medicine, focusing on Dermatology, acting on research lines HEALTH (1) and HEALTH / DERMATOLOGY (2), covering the following subjects: (1) Leg ulcer, Diabetes mellitus, New healing stimulants ( Latex biomembrane, Therapeutic laser, Low intensity ultrasound, plant extracts), experimental models, healing immunobiology, mesenchymal stem cells; guided bone regeneration and latex allergy (2) leprosy - skin immunomarkers of neuropathy and pathophysiology, in addition to assessing the importance of Sanitary Dermatology in primary health care; practical theoretical training in the field in several states of the country (PA; PE; PI; TO; RR; BA; DF and MT). (3) New methodologies for testing Safety and Efficacy in cosmetic products such as clinical and HUMAN EX-VIVO SKIN tests. Since 2008 involved with TECHNOLOGICAL DEVELOPMENT of the ex vivo HOSEC model - model for its various applications and implications, in addition to partnerships with public and private companies. Board Member of ILA - International Leprosy Association. In 2018, we began development of the SKIN ULTRASOUND area to improve the diagnosis of skin lesions and their differential diagnoses, correlating clinic, dermatoscopy, ultrasound and histopathology to residents and students. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Surprisingly leprosy still exists and affects around 200,000 people worldwide. Bone damage occurs in approximately 80% of leprosy patients, predominantly located at the hands, feet and face. Facial and acral skeletal deformities are historic hallmarks of leprosy. Mycobacterium leprae is the causative agent of leprosy, an obligate intracellular pathogen able to invade the peripheral nervou…
Leprosy is a chronic infectious disease caused by Mycobacterium leprae, which infects skin cells and peripheral nerves. The main consequence of the disease is deformities, leading to physical disability. The difficulties of health services regarding the diagnosis of different clinical forms, reactional states and an early identification of infected contacts are important factors that do n…
(Only some records are available in English at this moment)
Leprosy, a chronic infection caused by Mycobacterium leprae and M. lepromatosis, exhibits a wide range of clinical manifestations primarily affecting peripheral nerves and skin. Despite standard treatment with World Health Organization (WHO) multidrug therapy (MDT), the incidence of drug resistance is increasing, with Brazil reporting high relapse rates. In 2017, 1734 cases of relapses we…
Medicinal resistance in leprosy is related to: changes in drug absorption, inconsistency in treatment by patients, re-exposure to high bacillary loads, and metabolic and structural characteristics inherent to M. leprae, allowing for bacillary persistence after treatment, as well as genetic factors that lead to the occurrence of mutations in genes related to resistance. Considering the inc…
Leprosy is a chronic infectious disease caused by Mycobacterium leprae, which infects skin cells and peripheral nerves. The main consequence of the disease is deformities leading to physical disability. The difficulties experienced in the daily practice of health services regarding the diagnosis of different clinical forms, reaction states and the early identification of infected contacts…
Symptoms of Leprosy-like illnesses have been reported since ancient times in China. Leprosy is defined as an infectious and contagious disease of a chronic nature, with dermatoneurological manifestations and high disabling conditions. Brazil has a high load for the disease, with 12.2 cases detected for every 100 thousand inhabitants, placing it in second in the world, behind India only. A…
Leg ulcers can be defined as areas of loss of epidermal and dermal integrity leading to adjacent tissues. The chronification of such lesions is related to systemic factors, such as chronic venous insufficiency, diabetes mellitus and arterial hypertension, frequent comorbidities in the elderly population. For presenting several etiologies (Venous, arterial, diabetic, neuropathic, leprosy, …
(Only some records are available in English at this moment)
Bone defects assume importance in growing prevalence of chronic health conditions since fractures and critical defects should increase as the population ages. The bone healing depends on a dense vascular network that provides essential oxygen and nutrients, an important characteristic for the process of tissue regeneration. Conventional treatments require transplantation and extremely inv…
| 9 / 6 | Completed research grants |
| 2 / 2 | Ongoing scholarships in Brazil |
| 10 / 6 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 22 / 15 | All research grants and scholarships |
| Associated processes | |